Trending news
Analyze
Pricing
RedHill Biopharma

RedHill Biopharma

Work at RedHill Biopharma? Add yourself to this profile

RedHill Biopharma

RedHill Biopharma (NASDAQ/TASE: RDHL) is a biopharmaceutical company focused on development of late-stage drugs for inflammatory and gastrointestinal diseases

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$38,000,000
Post-IPO equity
$11,700,000
Employees

Team size

10+
Locations
HQ
Headquarters
$38,000,000 Post-IPO equity
finanzen.at

RedHill BioPharma raises $38m in Nasdaq offering | 22.12.16